1. PP2A as the Main Node of Therapeutic Strategies and Resistance Reversal in Triple-Negative Breast Cancer
   Henan Zhao et al, 2017, Molecules CrossRef
2. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
   Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
3. A Comparison of Tumor Biology in Primary Ductal CarcinomaIn SituRecurring as Invasive Carcinoma versus a NewIn Situ
   Wenjing Zhou et al, 2013, International Journal of Breast Cancer CrossRef
4. Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
   Li Zhang et al, 2015, BioMed Research International CrossRef
5. YAP transduction drives triple-negative breast cancer aggressiveness through modulating the EGFR‒AKT axis in patient-derived xenograft cells
   Sulfath Thottungal Parambil et al, 2023, Medical Oncology CrossRef